Pavlović, Nebojša
Results 1-20 of 21 (Search time: 0.003 seconds).
| Issue Date | Title | Author(s) | |
|---|---|---|---|
| 1 | 1-Jan-2016 | Advantages and disadvantages of emergency postcoital contraception | Svetlana Goločorbin-Kon ; Berina Kučević; Mladena Lalić-Popović ; Nebojša Pavlović ; Nataša Perišić Jeremić; Milena Perišić; Momir Mikov |
| 2 | 2017 | Antioxidant effects of ursodeoxycholic acid in doxorubicin-induced oxidative hepatocyte injury | Bojan Stanimirov ; Karmen Stankov ; Nebojša Pavlović ; Maja Đanić ; Svetlana Goločorbin-Kon ; Velibor Vasović ; Momir Mikov |
| 3 | 1-Jan-2013 | Application of bile acids in drug formulation and delivery | Maja Stojančević; Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Momir Mikov |
| 4 | 8-Nov-2018 | Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles | Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Maja Đanić ; Bojan Stanimirov ; Hani Al-Salami; Karmen Stankov ; Momir Mikov |
| 5 | 2019 | Botulinum toxin – poison, medicine and cosmetic preparation | Svetlana Goločorbin-Kon ; Nebojša Pavlović ; Saša Vukmirović ; Mladena Lalić-Popović ; Nataša Milošević ; Jelena Jovičić Bata ; Neda Gavarić ; Maja Đanić ; Nemanja Todorović ; Momir Mikov |
| 6 | 1-Jan-2016 | Docking-based preliminary study on the interactions of bile acids with drugs at the transporter level in intestinal bacteria | Maja Đanić ; Nebojša Pavlović ; Bojan Stanimirov ; Tijana Ostojić ; Svetlana Goločorbin-Kon ; Gordana Smieško ; Momir Mikov |
| 7 | Feb-2020 | DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal Impairment | Momir Mikov ; Nebojša Pavlović ; Bojan Stanimirov ; Maja Đanić ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Hani Al-Salami |
| 8 | 1-Jan-2019 | DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal Impairment | Mikov, Momir ; Pavlović, Nebojša ; Stanimirov, Bojan ; Đanić, Maja ; Goločorbin-Kon, Svetlana ; Stankov, Karmen ; Al-Salami H. |
| 9 | 2019 | In silico alternatives to animal testing: state of the art | Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Maja Đanić ; Bojan Stanimirov ; Mladena Lalić-Popović ; Momir Mikov |
| 10 | 1-Jan-2019 | In silico discovery of resveratrol analogues as potential agents in treatment of metabolic disorders | Nebojša Pavlović ; Maja Đanić ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Mladena Lalić-Popović ; Momir Mikov |
| 11 | 2018 | In vivo effects of ursodeoxycholic acid on doxorubicin-induced oxidative injury of hepatocyte | Bojan Stanimirov ; Karmen Stankov ; Nebojša Pavlović ; Maja Đanić ; Svetlana Goločorbin-Kon ; Momir Mikov |
| 12 | 1-Jan-2020 | The increasing doses of methotrexate pharmacokinetics after intravenous administration in rats - model selection | Ivana Rajšić; Nebojša Pavlović ; Boris Milijašević ; Saša Vukmirović ; Dragan Spasić ; Miodrag Žigić ; Nenad Grahovac ; Svetlana Goločorbin-Kon ; Momir Mikov |
| 13 | 1-Oct-2012 | An insight on differences in availability and reimbursement of orphan medicines among Serbia, Bulgaria and Sweden | Pavlović, Nebojša ; Stanimirov, Bojan ; Stojančević M.; Paut-Kusturica M.; Stoimenova A.; Goločorbin-Kon, Svetlana ; Mikov, Momir |
| 14 | 2016 | Methotrexate - an old drug with new pharmaceutical formulations and new indications | Svetlana Goločorbin-Kon ; Nebojša Pavlović ; Bojan Stanimirov ; Saša Vukmirović ; Boris Milijašević |
| 15 | 2-Sep-2016 | MICROVESICLE FORMULATION CONTAINING SODIUM 3 ,7 - DIHYDROXY-12- KETO-5 - CHOLANATE ENHANCES ORAL ABSORPTION OF CEFOTAXIME | Svetlana Goločorbin-Kon ; Nebojša Pavlović ; Mladena Lalić-Popović ; Boris Milijašević ; Bojan Stanimirov ; Saša Vukmirović ; Momir Mikov |
| 16 | 2019 | New pharmaceutical formulations and new indications for an old drug - methotrexate | Svetlana Goločorbin-Kon ; Nebojša Pavlović ; Saša Vukmirović ; Maja Đanić ; Boris Milijašević ; Milica Paut Kusturica ; Ana Tomas Petrović ; Bojan Stanimirov ; Hani Al-Salami; Momir Mikov |
| 17 | 2018 | Non-toxic bile acids as pharmaceutical excipients may alter pharmacological activity of antitumor drug vorinostat | Nebojša Pavlović ; Karmen Stankov ; Svetlana Goločorbin-Kon ; Mladena Lalić-Popović ; Bojan Stanimirov ; Maja Đanić ; Momir Mikov |
| 18 | 1-Jan-2018 | Pharmacological applications of bile acids and their derivatives in the treatment of metabolic syndrome | Maja Đanić ; Bojan Stanimirov ; Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Hani Al-Salami; Karmen Stankov ; Momir Mikov |
| 19 | 1-Jun-2018 | Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics | Momir Mikov ; Maja Đanić ; Nebojša Pavlović ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Hani Al-Salami |
| 20 | 1-Dec-2017 | The Role of Drug Metabolites in the Inhibition of Cytochrome P450 Enzymes | Momir Mikov ; Maja Đanić ; Nebojša Pavlović ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Hani Al-Salami |